Skip to main content
462 search results for:

TNF inhibitors 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 08-07-2022 | Rheumatoid arthritis | News | Article

    TNF inhibitors linked to higher psoriasis risk than other RA treatments

    Treatment with TNF inhibitors is associated with a twofold increased risk for new-onset psoriasis compared with nonbiologic agents, suggest findings from a Danish cohort study.

  2. 31-03-2022 | Rheumatoid arthritis | News | Article

    Real-world study suggests similar effectiveness of tofacitinib, TNF inhibitors

    Findings from a rheumatoid arthritis registry study suggest that the JAK inhibitor tofacitinib may have comparable real-world effectiveness to TNF inhibitors.

  3. 09-02-2022 | Juvenile idiopathic arthritis | News | Article

    TNF inhibitors linked to psoriasis risk in children with JIA

    Exposure to tumor necrosis factor inhibitors is associated with a threefold increased risk for developing psoriasis in children with juvenile idiopathic arthritis, US study findings indicate.

  4. 29-03-2022 | Ankylosing spondylitis | Adis Journal Club | Article
    BioDrugs

    Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry

    The efficacy and safety of TNF inhibitors was similar in patients with AS aged ≥ 50 and < 50 years.

  5. 21-10-2021 | Infection | News | Article

    TNF inhibitors linked to more serious infections in RA vs PsA

    Individuals with rheumatoid arthritis have a significantly higher risk for serious infections while receiving TNF inhibitor therapy than those with psoriatic arthritis, Norwegian researchers report.

  6. 10-11-2021 | ACR 2021 | Conference coverage | Article

    ORAL Surveillance: Tofacitinib fails to show noninferiority vs TNF inhibitors for MACE, malignancy risk

    The JAK inhibitor tofacitinib is associated with numerically higher rates of MACE and malignancy than TNF inhibitors in people with rheumatoid arthritis at high cardiovascular risk, show the ORAL Surveillance results.

  7. 09-11-2021 | ACR 2021 | Conference coverage | Article

    Olokizumab benefits extend to patients with RA refractory to methotrexate or TNF inhibitors

    Olokizumab shows clinical and physical benefits for patients with rheumatoid arthritis with inadequate responses to methotrexate and TNF inhibitor therapy in the latest CREDO findings.

  8. 28-09-2021 | Vaccination | News | Article

    Live attenuated zoster vaccine may be ‘reasonable option’ for people taking TNF inhibitors

    Findings from the VERVE trial suggest that the live attenuated zoster vaccine has favorable short-term immunogenicity and safety profiles in people with immune-mediated diseases treated with TNF inhibitors.

  9. 04-06-2021 | EULAR 2021 | Conference coverage | Article

    Guselkumab beneficial in PsA patients with inadequate response to TNF inhibitors

    Findings from the phase 3b COSMOS trial indicate that guselkumab, a selective monoclonal antibody targeting the IL-23 p19 subunit, may improve outcomes for patients with active psoriatic arthritis and an inadequate response to TNF inhibitors.

  10. 09-03-2021 | COVID-19 | Podcast | Article

    Repurposing rheumatology drugs for COVID-19: TNF inhibitors

    Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway (16:39).

  11. 27-07-2020 | Rheumatoid arthritis | News | Article

    Similar RA outcomes with TNF inhibitors vs other biologics, JAK inhibitors

    medwireNews : Findings from two real-world studies suggest that rheumatoid arthritis patients treated with TNF inhibitors experience similar clinical outcomes and rates of discontinuation to those given other biologics or JAK inhibitors.

  12. 02-09-2020 | Rheumatoid arthritis | News | Article

    Abatacept, TNF inhibitors linked to reduced CVD risk in RA

    A real-world comparison of biologic, targeted synthetic, and conventional DMARDs indicates that TNF inhibitors and abatacept are associated with a reduction in CVD risk in patients with rheumatoid arthritis.

  13. 04-06-2020 | EULAR 2020 | Conference coverage | Article
    News in brief

    ​​​​​​​TNF inhibitors linked to reduced VTE risk in RA patients

    Patients with rheumatoid arthritis who are treated with TNF inhibitors have a significantly lower risk for venous thromboembolism than those given conventional DMARDs, suggests an analysis of the German RABBIT registry.

  14. 29-07-2020 | Ankylosing spondylitis | News | Article

    TNF inhibitors may slow radiographic progression in ankylosing spondylitis

    Patients with ankylosing spondylitis taking TNF inhibitors experience slower rates of radiographic progression than those not taking TNF inhibitors, suggest long-term, real-world findings.

  15. play
    03-06-2020 | EULAR 2020 | Conference coverage | Video

    Researcher comment: TNF inhibitors linked to reduced VTE risk in RA patients

    Anja Strangfeld discusses an analysis of the German RABBIT registry comparing the risk for venous thromboembolism among patients with rheumatoid arthritis treated with different classes of medication (5:20).

  16. 05-03-2020 | Axial spondyloarthritis | News | Article

    TNF inhibitors may improve functional status in axial spondyloarthritis

    TNF inhibitors improve the functional status of patients with axial spondyloarthritis, with the degree of improvement in line with disease duration and activity, real-world data suggest.

  17. 24-03-2020 | TNF inhibitors | News | Article

    Increased neuroinflammatory disease risk with TNF inhibitors depends on arthritis type

    Research indicates that TNF inhibitor treatment is associated with an increased risk for developing neuroinflammatory disease in patients with psoriatic arthritis or ankylosing spondyloarthritis, but not in those with rheumatoid arthritis.

  18. 24-03-2020 | TNF inhibitors | Highlight | Teaser
    medwireNews top story

    Increased neuroinflammatory disease risk with TNF inhibitors depends on arthritis type

     Research indicates that tumor necrosis factor inhibitor treatment is associated with an increased risk for developing neuroinflammatory disease in patients with psoriatic arthritis or ankylosing spondyloarthritis, but not in those with rheumatoid arthritis.

  19. 10-02-2020 | Ankylosing spondylitis | News | Article

    TNF inhibitors may slow long-term radiographic progression in AS

    Tumor necrosis factor inhibitors may reduce long-term radiographic progression at the spine in patients with ankylosing spondylitis, results of a systematic review and meta-analysis show.

  20. 10-02-2020 | Ankylosing spondylitis | Highlight | Teaser
    medwireNews top story

    TNF inhibitors may slow long-term radiographic progression in AS

    Tumor necrosis factor inhibitors may reduce long-term radiographic progression at the spine in patients with ankylosing spondylitis, results of a systematic review and meta-analysis show.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.